Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development
- PMID: 31968673
- PMCID: PMC7157723
- DOI: 10.3390/vaccines8010035
Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development
Abstract
Herpesviruses have been isolated from a wide range of hosts including humans-for which, nine species have been designated. The human herpesviruses are highly host adapted and possess the capacity for latency, allowing them to survive in the host for life, effectively hidden from the immune system. This ability of human herpesviruses to modulate the host immune response poses particular challenges for vaccine development but at the same time proves attractive for the application of human herpesvirus vaccines to certain spheres of medicine. In this review, congenital cytomegalovirus (CMV) infection and hearing loss will be described followed by a comment on the status of current vaccine development. Secondly, the association of Epstein-Barr virus (EBV) infection with multiple sclerosis (MS) and how EBV vaccination may be of benefit will then be discussed. Prevention of congenital CMV by vaccination is an attractive proposition and several vaccines have been evaluated for potential use. Particularly challenging for the development of CMV vaccines are the needs to prevent primary infection, reinfection, and reactivation at the same time as overcoming the capacity of the virus to generate highly sophisticated immunomodulatory mechanisms. Cost and the practicalities of administering potential vaccines are also significant issues, particularly for low- and middle-income countries, where the burden of disease is greatest. An effective EBV vaccine that could prevent the 200,000 new EBV-associated malignancies which occur globally each year is not currently available. There is increasing interest in developing EBV vaccines to prevent MS and, in view of the association of infectious mononucleosis with MS, reducing childhood infectious mononucleosis is a potential intervention. Currently, there is no licensed EBV vaccine and, in order to progress the development of EBV vaccines for preventing MS, a greater understanding of the association of EBV with MS is required.
Keywords: Cytomegalovirus; Epstein–Barr virus; congenital infection; multiple sclerosis.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
The Potential for EBV Vaccines to Prevent Multiple Sclerosis.Front Neurol. 2022 Jun 24;13:887794. doi: 10.3389/fneur.2022.887794. eCollection 2022. Front Neurol. 2022. PMID: 35812097 Free PMC article.
-
Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.Inflamm Bowel Dis. 2019 Jun 18;25(7):1218-1226. doi: 10.1093/ibd/izy366. Inflamm Bowel Dis. 2019. PMID: 30551205
-
Vaccine Development for Epstein-Barr Virus.Adv Exp Med Biol. 2018;1045:477-493. doi: 10.1007/978-981-10-7230-7_22. Adv Exp Med Biol. 2018. PMID: 29896681 Free PMC article. Review.
-
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.J Virol. 2019 Nov 26;93(24):e00980-19. doi: 10.1128/JVI.00980-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31578295 Free PMC article.
-
[Prevention and therapy of herpesvirus infections].Zentralbl Bakteriol Mikrobiol Hyg B. 1985 Feb;180(2-3):107-20. Zentralbl Bakteriol Mikrobiol Hyg B. 1985. PMID: 2986378 Review. German.
Cited by
-
Herpesvirus Vaccines.Vaccines (Basel). 2022 Apr 18;10(4):628. doi: 10.3390/vaccines10040628. Vaccines (Basel). 2022. PMID: 35455377 Free PMC article.
-
Evaluation of Two Different CMV-Immunoglobulin Regimens for Combined CMV Prophylaxis in High-Risk Patients following Lung Transplant.Microorganisms. 2022 Dec 22;11(1):32. doi: 10.3390/microorganisms11010032. Microorganisms. 2022. PMID: 36677327 Free PMC article.
-
Apoptosis Disorder, a Key Pathogenesis of HCMV-Related Diseases.Int J Mol Sci. 2021 Apr 15;22(8):4106. doi: 10.3390/ijms22084106. Int J Mol Sci. 2021. PMID: 33921122 Free PMC article. Review.
-
Elevated Antibody Titers to Epstein-Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus.Viruses. 2023 Apr 17;15(4):986. doi: 10.3390/v15040986. Viruses. 2023. PMID: 37112967 Free PMC article.
-
Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways.Microorganisms. 2021 Jan 31;9(2):292. doi: 10.3390/microorganisms9020292. Microorganisms. 2021. PMID: 33572685 Free PMC article. Review.
References
-
- Virus Taxonomy: The Classification and Nomenclature of Viruses the Online (10th) Report of the ICTV. [(accessed on 20 December 2019)]; Available online: http://talk.ictvonline.org/ictv-reports/ictv_online_report/
Publication types
LinkOut - more resources
Full Text Sources